Biointegral Xenograft in Management of Aortofemoral Vascular Graft Infections

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F19%3A00008507" target="_blank" >RIV/00023884:_____/19:00008507 - isvavai.cz</a>

Výsledek na webu

<a href="https://austinpublishinggroup.com/" target="_blank" >https://austinpublishinggroup.com/</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Biointegral Xenograft in Management of Aortofemoral Vascular Graft Infections

Popis výsledku v původním jazyce

Aortic graft infections represent a major problem in modern vascular surgery. The issue of which specific material should be chosen for a new reconstruction in the infected area remains unsolved. We used a bioprosthesis made from bovine pericardium - Biointegral for 9 patients with intracavitary vascular graft infections between 2017 and 2019. The median age of the patients was 65 years, the average length of hospital stays was 28 days. The early 30 day mortality rate was 22%. Late graft occlusion occurred in two patients. In two cases, we had to treat infections of the biological prosthesis. Despite numerous complications, the use of the Biointegral xenograft may be a valuable option in certain cases of vascular graft infections. To compare the results of the treatment with other types of grafts, further studies would be necessary.

Název v anglickém jazyce

Biointegral Xenograft in Management of Aortofemoral Vascular Graft Infections

Popis výsledku anglicky

Aortic graft infections represent a major problem in modern vascular surgery. The issue of which specific material should be chosen for a new reconstruction in the infected area remains unsolved. We used a bioprosthesis made from bovine pericardium - Biointegral for 9 patients with intracavitary vascular graft infections between 2017 and 2019. The median age of the patients was 65 years, the average length of hospital stays was 28 days. The early 30 day mortality rate was 22%. Late graft occlusion occurred in two patients. In two cases, we had to treat infections of the biological prosthesis. Despite numerous complications, the use of the Biointegral xenograft may be a valuable option in certain cases of vascular graft infections. To compare the results of the treatment with other types of grafts, further studies would be necessary.

Druh

J_ost - Ostatní články v recenzovaných periodicích

CEP obor

—

OECD FORD obor

30213 - Transplantation

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Austin Journal of Surgery

ISSN

2381-9030

e-ISSN

—

Svazek periodika

6

Číslo periodika v rámci svazku

27

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

5

Strana od-do

—

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—